A New Approach to Alzheimer’s? | Lou Reese
American Thought Leaders
The Epoch Times
4.9 • 1.2K Ratings
🗓️ 23 January 2026
⏱️ 48 minutes
🧾️ Download transcript
Summary
A typical vaccine stimulates a person’s immune system, yet only a portion of the immune response actually targets the disease it’s designed to protect against. However, a new technology may be changing that dynamic.
In this episode, I sit down with Lou Reese, an entrepreneur who has led or co-founded several biotech companies and has been working on synthetic peptide-based active immunotherapy medicines. He’s co-CEO of United Biomedical and co-founder of Vaxxinity, Cana Life, and Axxium.
He’s working on a product that could—if proven successful—transform our approach to treating and preventing Alzheimer’s. He and his team also have a product that has shown preliminary promise in phase 1 trials in treating Parkinson’s.
In this episode, he also reveals an incredible story: He and his team previously developed a peptide-based active immunotherapy vaccine candidate for COVID-19, and they successfully completed Phase 1 and Phase 2 trials. Institutional backing, however, favored Pfizer and Moderna. In 2022, Lou Reese’s team was invited to the White House “Summit on the Future of COVID‑19 Vaccines,” where they presented their candidate as an alternative to Pfizer’s mRNA vaccine, which by then had been associated with serious side effects.
In the end, their product was never approved, and related content on YouTube was marked as misinformation.
Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | She said, we're giving out puberty blockers like candy. |
| 0:03.0 | You're talking about powerful, irreversible drugs and surgeries on kids. |
| 0:08.0 | It's very difficult for them to say, oops, we got this one wrong, |
| 0:12.0 | even if they actually come to that realization. |
| 0:14.0 | What 12-year-old can possibly understand what it means to never be able to have children in the future? |
| 0:20.0 | In this episode, I'm sitting down with Lear Sapir, a Manhattan Institute senior fellow and one |
| 0:25.7 | of the co-authors of the 400-page HHS review of pediatric gender medicine. |
| 0:31.5 | Sex is not assigned at birth, and to tell patients consistently in a medical setting where |
| 0:37.1 | figures of authority wearing white coats come into the room and tell parents, |
| 0:41.0 | the sex that you thought your daughter or son is, is not their true sex, is fundamentally unscientific and misleading. |
| 0:49.5 | This is American Thought Leaders, and I'm Yanya Kellick. |
| 0:57.0 | Leah Sapir, such a pleasure to have you on American Thought Leaders. |
| 1:00.0 | Thanks for having me back. |
| 1:02.0 | The term sex-rejecting procedures. It's one that I hadn't heard before but kind of makes a lot of sense to me. |
| 1:09.0 | Where did this come from? It's now largely used, |
| 1:13.2 | actually, in this lexicon, particularly by HHS. That's right. The administration adopted this term |
| 1:18.9 | in the last few months as an alternative to, certainly as an alternative to the standard term in the |
| 1:25.7 | field, which is gender affirming care. Gender affirming |
| 1:28.7 | care is a euphemism, and it is essentially a marketing term. And so it was clear to the administration, |
| 1:36.0 | in my view, that they didn't want to use this term. And there were a few other candidates, |
| 1:40.2 | sex trait modification being one. But sex rejecting procedures, the advantage of the term is that it conveys the intent |
| 1:46.2 | behind the use of puberty blockers, cross-sex hormones, and surgeries to treat a condition |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Epoch Times, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Epoch Times and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

